Sagittarius Life Science Corp (TPEX:3205)

Market Cap	3.06B
Revenue (ttm)	424.44M
Net Income (ttm)	-46.33M
Shares Out	67.55M
EPS (ttm)	-1.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	53,935
Average Volume	131,304
Open	45.20
Previous Close	45.30
Day's Range	44.85 - 46.00
52-Week Range	21.30 - 61.60
Beta	0.72
RSI	40.78
Earnings Date	Nov 13, 2025

About Sagittarius Life Science

Sagittarius Life Science Corp engages in the research, development, and sale of Chinese and western medicines, and health food products in Taiwan and Asia. It also offers organic food, daily necessities, and pet food; and engages in the research and development of biotechnology. Sagittarius Life Science Corp was founded in 1998 and is based in Taipei, Taiwan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 112
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 3205

Financial Performance

In 2024, Sagittarius Life Science's revenue was 467.75 million, an increase of 6.20% compared to the previous year's 440.46 million. Losses were -48.53 million, -11.82% less than in 2023.